You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 264 No. 3, July 18, 1990 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Normal-Pressure Hydrocephalus

Wei-Jen Shih, MD; Phillip A. Tibbs, MD
University of Kentucky Medical Center Lexington

JAMA. 1990;264(3):336.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Dr Friedland1 presents impressive positron emission tomographic images made before and after the placement of a shunt in a patient with normal-pressure hydrocephalus. The images show postoperative recovery in cerebral glucose metabolism, especially pronounced in the temporal and parietal cortices. Positron emission tomography using fludeoxyglucose F 18 may become a routine procedure for evaluation before and after operation in patients with normal-pressure hydrocephalus.

While the study by Dr Friedland used computed tomography, magnetic resonance imaging, and positron emission tomography for diagnostic imaging and postoperative evaluation, he made no mention of radionuclide (indium 111-labeled pentetic acid or ytterbium 169-labeled pentetate) cisternography for the diagnosis of normal-pressure hydrocephalus. We believe that radionuclide cisternography can provide information on the status of the cerebrospinal circulation. Images of the head taken at 3 to 6, 24, and 48 hours following the intrathecal injection of 0.5 to 1.0 mCi of111 Inlabeled . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.